Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PCN Stock Summary
Top 10 Correlated ETFs
PCN
In the News
PCN Financial details
Company Rating
Buy
Market Cap
638.16M
Income
94.07M
Revenue
109.04M
Book val./share
12.19
Cash/share
1.31
Dividend
1.35
Dividend %
10.69%
Employees
-
Optionable
No
Shortable
Yes
Earnings
05 Mar 2024
P/E
12.05
Forward P/E
-
PEG
-0.59
P/S
14.26
P/B
0.92
P/C
9.81
P/FCF
3.47
Quick Ratio
2.01
Current Ratio
2.01
Debt / Equity
0.2
LT Debt / Equity
-
-
-
EPS (TTM)
1.89
EPS next Y
-
EPS next Q
-
EPS this Y
-157.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.9%
Revenue last 5Y
-5.35%
Revenue Q/Q
-99.78%
EPS Q/Q
368.18%
-
-
-
-
SMA20
-7.14%
SMA50
-
SMA100
8.33%
Inst Own
11%
Inst Trans
0.83%
ROA
6%
ROE
8%
ROC
0.06%
Gross Margin
100%
Oper. Margin
99%
Profit Margin
99%
Payout
149%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.7-14.48
52W High
-8.21%
52W Low
+28.5%
RSI
27
Rel Volume
0.21
Avg Volume
216.13K
Volume
45.27K
Perf Week
-4.89%
Perf Month
-4.6%
Perf Quarter
14.53%
Perf Half Y
17.67%
-
-
-
-
Beta
0.911
-
-
Volatility
0.2%, 0.46%
Prev Close
0.16%
Price
12.85
Change
-0.08%
PCN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.4 | -0.77 | 3.02 | -1.82 | 1.05 | |
Net income per share | 1.39 | -0.77 | 3.01 | -1.83 | 1.05 | |
Operating cash flow per share | 0.04 | 1.24 | -5.69 | 3.49 | 4.33 | |
Free cash flow per share | 0.04 | 1.24 | -5.69 | 3.49 | 4.33 | |
Cash per share | 0.37 | 0.66 | 0.06 | 1.18 | 0.05 | |
Book value per share | 14.94 | 12.76 | 15.1 | 12.13 | 13.75 | |
Tangible book value per share | 14.94 | 12.76 | 15.1 | 12.13 | 13.75 | |
Share holders equity per share | 14.94 | 12.76 | 15.1 | 12.13 | 13.75 | |
Interest debt per share | 8.18 | 8.3 | 10.41 | 12.67 | 2.78 | |
Market cap | 716.49M | 610.47M | 759.25M | 555.87M | 525.82M | |
Enterprise value | 875.61M | 773.75M | 1.17B | 790.88M | 628.28M | |
P/E ratio | 12.96 | -19.83 | 6.29 | -6.92 | 12.5 | |
Price to sales ratio | 12.88 | -19.95 | 6.28 | -6.94 | 12.44 | |
POCF ratio | 492.1 | 12.34 | -3.33 | 3.63 | 3.03 | |
PFCF ratio | 492.1 | 12.34 | -3.33 | 3.63 | 3.03 | |
P/B Ratio | 1.21 | 1.2 | 1.25 | 1.04 | 0.95 | |
PTB ratio | 1.21 | 1.2 | 1.25 | 1.04 | 0.95 | |
EV to sales | 15.74 | -25.29 | 9.71 | -9.87 | 14.86 | |
Enterprise value over EBITDA | 15.84 | -25.13 | 9.73 | -10.08 | 14.94 | |
EV to operating cash flow | 601.38 | 15.64 | -5.15 | 5.16 | 3.62 | |
EV to free cash flow | 601.38 | 15.64 | -5.15 | 5.16 | 3.62 | |
Earnings yield | 0.08 | -0.05 | 0.16 | -0.14 | 0.08 | |
Free cash flow yield | 0 | 0.08 | -0.3 | 0.28 | 0.33 | |
Debt to equity | 0.54 | 0.64 | 0.69 | 1.04 | 0.19 | |
Debt to assets | 0.4 | 0.42 | 0.38 | 0.65 | 0.15 | |
Net debt to EBITDA | 2.88 | -5.3 | 3.44 | -2.99 | 2.44 | |
Current ratio | 2.08 | 0.5 | 0.68 | 2.54 | 2.01 | |
Interest coverage | 14.55 | -8.11 | 76.91 | -42.87 | 5.21 | |
Income quality | 0.03 | -1.61 | -1.89 | -1.91 | 4.13 | |
Dividend Yield | 0.08 | 0.08 | 0.07 | 0.09 | 0.12 | |
Payout ratio | 0.98 | -1.68 | 0.41 | -0.59 | 1.49 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 21.65 | 14.88 | 31.99 | 22.34 | 18.01 | |
ROIC | 0.01 | -0.1 | 0 | -0.12 | 0 | |
Return on tangible assets | 0.07 | -0.04 | 0.11 | -0.09 | 0.06 | |
Graham Net | -4.34 | -5.44 | -11.8 | -5.59 | -3.23 | |
Working capital | 14.15M | -32.63M | -15.81M | 48.97M | 10.3M | |
Tangible asset value | 591.93M | 509.49M | 605.83M | 533.07M | 551.44M | |
Net current asset value | -179.16M | -234.85M | -466.01M | -243.86M | -125.11M | |
Invested capital | 0.54 | 0.64 | 0.69 | 1.04 | 0.19 | |
Average receivables | 19.1M | 29.66M | 32.78M | 35.9M | 29.01M | |
Average payables | 13.3M | 39.14M | 57.39M | 40.65M | 20.95M | |
Average inventory | -960K | -1.17M | -1.19M | -2.99M | -2.69M | |
Days sales outstanding | 178.69 | -382.62 | 101.04 | -174.59 | 170.06 | |
Days payables outstanding | 914.14 | 5K | 0 | 2.26K | 0 | |
Days of inventory on hand | -134.07 | -32.9 | 0 | -287.27 | 0 | |
Receivables turnover | 2.04 | -0.95 | 3.61 | -2.09 | 2.15 | |
Payables turnover | 0.4 | 0.07 | 0 | 0.16 | 0 | |
Inventory turnover | -2.72 | -11.1 | 0 | -1.27 | 0 | |
ROE | 0.09 | -0.06 | 0.2 | -0.15 | 0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.37 | 1.61 | 0.35 | 0.35 | 0 | |
Net income per share | 0.21 | 0.42 | 0.22 | 0.22 | 1.03 | |
Operating cash flow per share | 1.21 | 0.95 | 0.62 | 0.62 | 0.54 | |
Free cash flow per share | 1.21 | 0.95 | 0.62 | 0.62 | 0.54 | |
Cash per share | 0.06 | 0.1 | 0.04 | 0.04 | 1.31 | |
Book value per share | 11.77 | 11.26 | 11.61 | 11.14 | 12.19 | |
Tangible book value per share | 11.77 | 11.26 | 11.61 | 11.14 | 12.19 | |
Share holders equity per share | 11.77 | 11.26 | 11.61 | 11.14 | 12.19 | |
Interest debt per share | 0.03 | 7.68 | 0.08 | 2.09 | 2.48 | |
Market cap | 548.42M | 548.88M | 620.91M | 649.13M | 634.55M | |
Enterprise value | 546.6M | 722.95M | 620.11M | 751.59M | 755.05M | |
P/E ratio | 14.43 | 7.02 | 14.36 | 15.01 | 3 | |
Price to sales ratio | 32.35 | 7.37 | 35.94 | 37.57 | 16.7K | |
POCF ratio | 9.79 | 12.45 | 20.16 | 21.08 | 23.15 | |
PFCF ratio | 9.79 | 12.45 | 20.16 | 21.08 | 23.15 | |
P/B Ratio | 1.01 | 1.05 | 1.08 | 1.18 | 1.02 | |
PTB ratio | 1.01 | 1.05 | 1.08 | 1.18 | 1.02 | |
EV to sales | 32.25 | 9.71 | 35.89 | 43.5 | 19.87K | |
Enterprise value over EBITDA | -86.72 | 25.43 | -118.39 | -143.49 | 13.12 | |
EV to operating cash flow | 9.76 | 16.4 | 20.13 | 24.4 | 27.54 | |
EV to free cash flow | 9.76 | 16.4 | 20.13 | 24.4 | 27.54 | |
Earnings yield | 0.02 | 0.04 | 0.02 | 0.02 | 0.08 | |
Free cash flow yield | 0.1 | 0.08 | 0.05 | 0.05 | 0.04 | |
Debt to equity | 0 | 0.67 | 0.01 | 0.19 | 0.2 | |
Debt to assets | 0 | 0.47 | 0.01 | 0.15 | 0.16 | |
Net debt to EBITDA | 0.29 | 6.12 | 0.15 | -19.56 | 2.09 | |
Current ratio | 0.6 | 1.44 | 0.71 | 2.01 | 0 | |
Interest coverage | 0 | 7.21 | 0 | 0 | 13.93 | |
Income quality | 5.73 | 2.25 | 2.74 | 2.74 | 0.52 | |
Dividend Yield | 0.03 | 0.06 | 0.02 | 0.02 | 0.05 | |
Payout ratio | 1.76 | 1.71 | 1.35 | 1.35 | 0.58 | |
Sales general and administrative to revenue | 0.07 | 0.02 | 0.07 | 0.07 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.37 | 10.34 | 7.55 | 7.4 | 16.84 | |
ROIC | 0.05 | 0.01 | 0.04 | 0.03 | 0.08 | |
Return on tangible assets | 0.01 | 0.03 | 0.02 | 0.02 | 0.07 | |
Graham Net | -3.92 | -4.39 | -2.14 | -2.61 | -1.08 | |
Working capital | -79.52M | 10.32M | -33.66M | 10.3M | -122.92M | |
Tangible asset value | 545.2M | 521.65M | 574.99M | 551.44M | 623.21M | |
Net current asset value | -87.68M | -198.99M | -40.14M | -125.11M | -136.72M | |
Invested capital | 0 | 0.67 | 0.01 | 0.19 | 0.2 | |
Average receivables | 0 | 33.7M | 26.7M | 19.7M | 0 | |
Average payables | 0 | 20.78M | 13.99M | 7.4M | 0 | |
Average inventory | 0 | -813K | -1.08M | -1.35M | 0 | |
Days sales outstanding | 178.92 | 40.74 | 102.6 | 102.6 | 46.4K | |
Days payables outstanding | 0 | 921.03 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | -32.02 | 0 | 0 | 0 | |
Receivables turnover | 0.5 | 2.21 | 0.88 | 0.88 | 0 | |
Payables turnover | 0 | 0.1 | 0 | 0 | 0 | |
Inventory turnover | 0 | -2.81 | 0 | 0 | 0 | |
ROE | 0.02 | 0.04 | 0.02 | 0.02 | 0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
PCN Frequently Asked Questions
What is PIMCO Corporate & Income Strategy Fund stock symbol ?
PIMCO Corporate & Income Strategy Fund is a US stock , located in Newport beach of Ca and trading under the symbol PCN
What is PIMCO Corporate & Income Strategy Fund stock quote today ?
PIMCO Corporate & Income Strategy Fund stock price is $12.85 today.
Is PIMCO Corporate & Income Strategy Fund stock public?
Yes, PIMCO Corporate & Income Strategy Fund is a publicly traded company.